ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96.

Jin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.